• Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

AXA Framlington Biotech Fund

+ Add to Watchlist

FRABIOZ:LN

278.50 GBp 9.70 3.61%

As of 00:59:30 ET on 12/19/2014.

Snapshot for AXA Framlington Biotech Fund (FRABIOZ)

Year To Date: +50.36% 3-Month: +22.36% 3-Year: - 52-Week Range: 173.61 - 278.50
1-Month: +8.37% 1-Year: +53.34% 5-Year: - Beta vs NBI: 0.93

Mutual Fund Chart for FRABIOZ

No chart data available.
  • FRABIOZ:LN 278.50
  • 1M
  • 1Y
Interactive FRABIOZ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FRABIOZ

AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.

Inception Date: 04-16-2012 Telephone: 44-207-374-4100
Managers: LINDEN THOMSON / GEMMA GAME
Web Site: www.axa-framlington.com

Fundamentals for FRABIOZ

NAV (on 2014-12-19) 278.50
Assets (M) (on 2014-11-27) 477.91
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment 5,000.00

Dividends for FRABIOZ

Dividend Type Omitted
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for FRABIOZ

Front Load 0.00
Back Load -
Current Mgmt Fee 0.75
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for FRABIOZ

Filing Date: 10/31/2014
Name Position Value % of Total
Celgene Corp 618,528 41,414,400 9.600%
Amgen Inc 397,172 40,120,200 9.300%
Gilead Sciences Inc 455,880 31,923,600 7.400%
Biogen Idec Inc 137,532 27,609,600 6.400%
Vertex Pharmaceuticals Inc 318,528 22,432,800 5.200%
Illumina Inc 164,810 19,844,400 4.600%
Regeneron Pharmaceuticals Inc 78,861 19,413,000 4.500%
Alexion Pharmaceuticals Inc 147,833 17,687,400 4.100%
BioMarin Pharmaceutical Inc 292,719 15,099,000 3.500%
Incyte Corp 318,959 13,373,400 3.100%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil